Key Insights

Highlights

Treatment Research

1 treatments under study, led by Pv10 10 Rose Bengal Disodium

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00986661Phase 1UnknownPrimary

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Showing all 1 trials

Research Network

Common Treatments

  • Pv10 10 Rose Bengal Disodium1

Active Sponsors

  • Provectus Biopharmaceuticals, Inc.1

Top Investigators

Related Conditions

  • Metastatic Ocular Melanoma1
  • Metastatic Melanoma1
  • Metastatic Lung Cancer1
  • Metastatic Pancreatic Cancer1
  • Hepatocellular Carcinoma1

Activity Timeline